ExOne Opens State-of-the-Art Metal 3D Printing Adoption Center in Europe, Expands Engineering Support
The ExOne Company (Nasdaq: XONE), the global leader in industrial sand and metal 3D printers using binder jetting technology, today announced it has opened a Metal 3D Printing Adoption Center at its European headquarters in Gersthofen, Germany.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210708005298/en/
Eric Bader, Managing Director of ExOne GmbH, says the launch of ExOne's Metal 3D Printing Adoption Center is driven by increased interest by European manufacturers in metal binder jet 3D printing. ExOne’s Adoption Centers now print sand molds and cores for metalcasting customers, as well as metal benchmarks for its metal binder jetting engineering consulting services. (Photo: Business Wire)
The mission of ExOne’s Adoption Centers, which have locations in the U.S., Germany, and Japan, is to allow customers to try binder jet 3D printing for their designs before they decide to buy an ExOne 3D printing system for their own production.
The investment announced today represents an expansion of ExOne’s longtime Adoption Center in Europe, which 3D prints sand molds and cores for metalcasting customers. ExOne’s Metal Adoption Center now offers manufacturers end-to-end engineering services for direct-metal binder jet 3D printing, including benchmarks, design support, and materials, process, and work cell development.
“Now, manufacturers throughout Europe can benefit from locally produced binder jetted metal designs and benchmarks, along with world-class engineering consultation and support,” said John Hartner, ExOne’s CEO. “We encourage manufacturers to take advantage of the high speed, low cost, and industry-leading quality that our patented binder jetting technology can deliver for even the most complex designs.”
“Our centralized location outside of Munich gives manufacturers the opportunity to see metal binder jetting in action and work closely with our expanded metal team on precision metal parts projects,” said Eric Bader, Managing Director, ExOne GmbH. “This expansion is supported by increased interest in metal binder jetting in Europe as the technology matures.”
High-Quality Metal Parts Key Focus of New Center
Binder jetting is a high-speed method of 3D printing in which an industrial inkjet printhead selectively deposits a binder into a bed of powder particles creating a solid part one thin layer at a time. When printing metals, the final part must be sintered in a furnace to fuse the particles together into a high-density solid object.
All new ExOne metal printers, such as the X1 160Pro manufactured on-site in Gersthofen, are now offered with the company’s patented Triple Advanced Compaction Technology (ACT), which delivers industry-leading accuracy, density, and repeatability in binder jet printing.
ExOne has now qualified more than 20 metal, ceramic, and composite materials for its binder jetting process. More than half of those materials are single-alloy metals, such as 17-4PH, 316L, 304L, M2 Tool Steel, Inconel 718, and more. Most recently, ExOne announced that 6061 aluminum is now a Customer-Qualified material, and titanium is now fast-tracked for qualification in partnership with a global medical device firm.
ExOne’s New Metal 3D Printing Adoption Center will initially focus on the delivery of small-to-medium parts with quality similar to Metal Injection Molding (MIM) in 316L and 17-4PH, with other materials available. To exploring having your part or product metal 3D printed with ExOne technology, contact ExOne through exone.com/EMEAmetal or +49 821 65063 238.
About ExOne
ExOne is the pioneer and global leader in binder jet 3D printing technology. Since 1995, we’ve been on a mission to deliver powerful 3D printers that solve the toughest problems and enable world-changing innovations. Our 3D printing systems quickly transform powder materials — including metals, ceramics, composites and sand — into precision parts, metalcasting molds and cores, and innovative tooling solutions. Industrial customers use our technology to save time and money, reduce waste, improve their manufacturing flexibility, and deliver designs and products that were once impossible. As home to the world’s leading team of binder jetting experts, ExOne also provides specialized 3D printing services, including on-demand production of mission-critical parts, as well as engineering and design consulting. Learn more about ExOne at www.exone.com or on Twitter at @ExOneCo. We invite you to join with us to #MakeMetalGreen™.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210708005298/en/
Contact information
Sarah Webster
724.516.2336
sarah.webster@exone.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Curatis: FDA Minutes Confirm Positive Outcome of Meeting on 9. September 2025 – Corticorelin on Track for Phase 318.9.2025 08:00:00 EEST | Press release
Curatis Holding AG (SIX:CURN) received the official minutes from the FDA meeting which took place on 9. September. Based on the totality of the feedback and discussions, Curatis can proceed as planned with the clinical development of corticorelin. Corticorelin is under development as a novel treatment intended to reduce or even eliminate steroid use and associated toxicities thereby potentially impacting the quality of life of patients suffering from peritumoral brain edema (PTBE) associated with metastatic (secondary) brain tumors. The virtual meeting with the FDA provided the opportunity to discuss the clinical development plan for corticorelin and encompassed CMC (Chemistry, Manufacturing and Control), nonclinical and clinical aspects. The offical FDA minutes which Curatis received after publication of the half year results reflect the positive outcome. Curatis may proceed without delay to a regulatory submission supporting a pivotal study in patients suffering from PTBE secondary t
Merck Opens Climate-Neutral €150 Million Filter Manufacturing Facility in Ireland18.9.2025 08:00:00 EEST | Press release
Merck, a leading science and technology company, has opened today its €150 million filter manufacturing facility in Blarney Business Park, Cork, Ireland. The site is Merck’s first manufacturing facility designed for full climate-neutral operations, marking a key milestone in the company’s ambition to achieve climate neutrality by 2040. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250917767425/en/ Merck's new Blarney site in Cork expands company's filter capacity, creating 200+ jobs by 2028 The 3,000-square-meter cleanroom facility supports global demand for critical filtration products used in the manufacturing of vaccines and life-saving therapies, including monoclonal antibodies, and emerging modalities like cell and gene therapies. By localizing these capacities in Europe, Merck hopes to reduce cross-border dependencies for the company’s customers. “Ireland is a leading hub for biopharmaceutical manufacturing and innova
Galderma Launches Transformative Skincare Segment With Cetaphil’s New Skin Activator Hydrating & Firming Line, in Partnership With Actor and Filmmaker Mariska Hargitay18.9.2025 08:00:00 EEST | Press release
Galderma today announced Cetaphil, the dermatologist-recommended brand trusted by millions with sensitive skin, is redefining daily skincare with its new Skin Activator Hydrating & Firming line. The launch marks an entirely new skincare segment of advanced hydration and firming solutions designed specifically for improving the appearance of aging, thinning, and fragile skin. As people age, surface skin cells stop performing at the same level, or “go to sleep,” causing fine lines, dehydration, and looser skin, in turn leading to skin looking and feeling less firm and more fragile.1 Skin Activator technology serves as a “wake-up call” to sleeping surface skin cells. The unique complex is powered by encapsulated CICA to help restore the skin’s moisture barrier to visibly plump and firm skin as well as microdosed mandelic acid to increase surface skin cell turnover to visibly reduce dull, uneven skin. In clinical trials, the Skin Activator Hydrating & Firming Lotion showed to be effective
Deciphera Receives European Commission Approval of ROMVIMZA™ (vimseltinib) for the Treatment of Tenosynovial Giant Cell Tumor (TGCT)17.9.2025 22:46:00 EEST | Press release
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced that the European Commission (EC) has approved ROMVIMZA™ (vimseltinib) in the European Union (EU) for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with clinically relevant physical function deterioration and in whom surgical options have been exhausted or would induce unacceptable morbidity or disability1. “The European Commission’s approval of vimseltinib for TGCT is a significant milestone for Deciphera, ONO, and TGCT patients across the European Union who are in need of a non-invasive treatment option. We are excited to leverage our global commercial infrastructure to bring vimseltinib to these patients,” said Ryota Udagawa, President and Chief Executive Officer of Deciphera. “We look forward to working with health authorities to ensure all eligible patients who can benefit from vimseltinib have access as quickly as p
Northern Escape Heli-Skiing Sees Global Surge in Demand as Adventurers Seek Canada’s Legendary Powder17.9.2025 19:09:00 EEST | Press release
Luxury adventure travel continues accelerating, with analysts projecting ~7.6% annual growth through 2030 [1][5]. Meanwhile, global tourism reached record highs in 2024 [2], and ski tourism is above pre-pandemic norms [3]. Northern Escape Heli-Skiing (NEH), named World’s Best Heli-Ski Operator by the World Ski Awards [4] in 2022, 2023, and 2024, continues to welcome a truly international mix of guests each winter. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250909723150/en/ Global Appeal Post-pandemic travellers prioritize remote, nature-led adventures and privacy-forward itineraries [1][3]. Adventure tourism is on a sharp upswing globally [5], while research highlights how social media and influencer content accelerate demand for marquee mountain experiences [7]. At the same time, heli-sports are forecast to expand steadily across Canada, Europe, APAC, and South America [8]. World’s Best Heli-Ski NEH operates in BC’s Ske
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom